Ming -- thanks. I believe the paper published in the Journal of Forensic Sciences is the one I was referring to. There was mention earlier in the year that two papers were scheduled for publication -- one at the end of July and the second in winter.
So I guess that begs the question: why such a discrepancy? (you knew that was coming. lol)
I guess the easy answer is that the dozen or so public companies that are screening the genome are already locked into a particular research method and can't change course without incurring substantial setbacks. Just think how expensive it would be for Dnaprint to alter its research focus at this point - we couldn't do it. University research departments aren't stratified by layers of management and have more flexible design teams.
But I wonder if there's not a better, less obvious reason.